4-Bromo-N-(dimethyloxido-λ4-sulfanylidene)-benzenamine
CAS: 56158-10-2
Ref. 3D-GCA15810
| 25mg | 294,00 € | ||
| 250mg | 1.101,00 € |
Información del producto
4-Bromo-N-(dimethyloxido-λ4-sulfanylidene)benzenamine is a pandemic influenza drug that has been shown to have antiviral activity against the H1N1 virus. Covid-19, the active ingredient in 4-Bromo-N-(dimethyloxido-λ4-sulfanylidene)benzenamine, is a nucleoside analog that inhibits viral replication by blocking the interaction between viral RNA polymerase and host cell ribosomes. Covid-19 has been shown to be effective against laboratory strains of H1N1 and H3N2 influenza A viruses and is currently undergoing clinical trials. Covid-19 also has antiviral activity against other respiratory viruses such as SARS coronavirus and human metapneumovirus.
Propiedades químicas
Consulta técnica sobre: 3D-GCA15810 4-Bromo-N-(dimethyloxido-λ4-sulfanylidene)-benzenamine
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
